Ethical issues in colorectal cancer screening
Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jun...
Gespeichert in:
Veröffentlicht in: | Baillière's best practice & research. Clinical gastroenterology 2014-04, Vol.28 (2), p.315-326 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 326 |
---|---|
container_issue | 2 |
container_start_page | 315 |
container_title | Baillière's best practice & research. Clinical gastroenterology |
container_volume | 28 |
creator | van Dam, Leonie, MD, PhD Bretthauer, Michael, MD, PhD |
description | Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review. |
doi_str_mv | 10.1016/j.bpg.2014.03.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1535631776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521691814000262</els_id><sourcerecordid>3294637491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</originalsourceid><addsrcrecordid>eNp9kc1LAzEQxYMotlb_AC9S8OJl18wkm-0iCCJ-geBBPYdsMtXU7W5NWsH_3iz1A3rwlCG895j3G8YOgefAQZ3O8nrxkiMHmXORc45bbAiFwAwqUNv9jJCpCiYDthfjjPNkqqpdNkA5SQEVDll2tXz11jRjH-OK4ti3Y9s1XSC7TJ_WtJbCONpA1Pr2ZZ_tTE0T6eD7HbHn66uny9vs_uHm7vLiPrNK4jIzQipeSCNNbWpXKScIJo5UWWNNKBw4YaG2hSyNwxKraVFMytJUIEFgLadixE7WuYvQvae1lnruo6WmMS11q6hTyUIJKEuVpMcb0lm3Cm3aTvf1ueAImFSwVtnQxRhoqhfBz0341MB1z1LPdGKpe5aaC51YJs_Rd_KqnpP7dfzAS4KztYASig9PQUfrKRFzvuenXef_jT_fcNvGt_0t3uiT4l8LHVFz_di36W8JMt0RFYovz32Wlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521030212</pqid></control><display><type>article</type><title>Ethical issues in colorectal cancer screening</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</creator><creatorcontrib>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</creatorcontrib><description>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</description><identifier>ISSN: 1521-6918</identifier><identifier>EISSN: 1532-1916</identifier><identifier>DOI: 10.1016/j.bpg.2014.03.002</identifier><identifier>PMID: 24810192</identifier><identifier>CODEN: BPRCB6</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Clinical trials ; Colonography, Computed Tomographic ; Colorectal cancer ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - prevention & control ; CT-colonography ; Early Detection of Cancer - ethics ; Endoscopy ; Endoscopy, Gastrointestinal ; Ethics ; Faecal occult blood test ; Gastroenterology and Hepatology ; Hospitals ; Humans ; Mass Screening - ethics ; Medical screening ; Mortality ; Occult Blood ; Occult sciences ; screening</subject><ispartof>Baillière's best practice & research. Clinical gastroenterology, 2014-04, Vol.28 (2), p.315-326</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</citedby><cites>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1521691814000262$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24810192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Dam, Leonie, MD, PhD</creatorcontrib><creatorcontrib>Bretthauer, Michael, MD, PhD</creatorcontrib><title>Ethical issues in colorectal cancer screening</title><title>Baillière's best practice & research. Clinical gastroenterology</title><addtitle>Best Pract Res Clin Gastroenterol</addtitle><description>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</description><subject>Clinical trials</subject><subject>Colonography, Computed Tomographic</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - prevention & control</subject><subject>CT-colonography</subject><subject>Early Detection of Cancer - ethics</subject><subject>Endoscopy</subject><subject>Endoscopy, Gastrointestinal</subject><subject>Ethics</subject><subject>Faecal occult blood test</subject><subject>Gastroenterology and Hepatology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Mass Screening - ethics</subject><subject>Medical screening</subject><subject>Mortality</subject><subject>Occult Blood</subject><subject>Occult sciences</subject><subject>screening</subject><issn>1521-6918</issn><issn>1532-1916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1LAzEQxYMotlb_AC9S8OJl18wkm-0iCCJ-geBBPYdsMtXU7W5NWsH_3iz1A3rwlCG895j3G8YOgefAQZ3O8nrxkiMHmXORc45bbAiFwAwqUNv9jJCpCiYDthfjjPNkqqpdNkA5SQEVDll2tXz11jRjH-OK4ti3Y9s1XSC7TJ_WtJbCONpA1Pr2ZZ_tTE0T6eD7HbHn66uny9vs_uHm7vLiPrNK4jIzQipeSCNNbWpXKScIJo5UWWNNKBw4YaG2hSyNwxKraVFMytJUIEFgLadixE7WuYvQvae1lnruo6WmMS11q6hTyUIJKEuVpMcb0lm3Cm3aTvf1ueAImFSwVtnQxRhoqhfBz0341MB1z1LPdGKpe5aaC51YJs_Rd_KqnpP7dfzAS4KztYASig9PQUfrKRFzvuenXef_jT_fcNvGt_0t3uiT4l8LHVFz_di36W8JMt0RFYovz32Wlw</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>van Dam, Leonie, MD, PhD</creator><creator>Bretthauer, Michael, MD, PhD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Ethical issues in colorectal cancer screening</title><author>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Clinical trials</topic><topic>Colonography, Computed Tomographic</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - prevention & control</topic><topic>CT-colonography</topic><topic>Early Detection of Cancer - ethics</topic><topic>Endoscopy</topic><topic>Endoscopy, Gastrointestinal</topic><topic>Ethics</topic><topic>Faecal occult blood test</topic><topic>Gastroenterology and Hepatology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Mass Screening - ethics</topic><topic>Medical screening</topic><topic>Mortality</topic><topic>Occult Blood</topic><topic>Occult sciences</topic><topic>screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Dam, Leonie, MD, PhD</creatorcontrib><creatorcontrib>Bretthauer, Michael, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Baillière's best practice & research. Clinical gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Dam, Leonie, MD, PhD</au><au>Bretthauer, Michael, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethical issues in colorectal cancer screening</atitle><jtitle>Baillière's best practice & research. Clinical gastroenterology</jtitle><addtitle>Best Pract Res Clin Gastroenterol</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>28</volume><issue>2</issue><spage>315</spage><epage>326</epage><pages>315-326</pages><issn>1521-6918</issn><eissn>1532-1916</eissn><coden>BPRCB6</coden><abstract>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>24810192</pmid><doi>10.1016/j.bpg.2014.03.002</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1521-6918 |
ispartof | Baillière's best practice & research. Clinical gastroenterology, 2014-04, Vol.28 (2), p.315-326 |
issn | 1521-6918 1532-1916 |
language | eng |
recordid | cdi_proquest_miscellaneous_1535631776 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Clinical trials Colonography, Computed Tomographic Colorectal cancer Colorectal Neoplasms - diagnosis Colorectal Neoplasms - prevention & control CT-colonography Early Detection of Cancer - ethics Endoscopy Endoscopy, Gastrointestinal Ethics Faecal occult blood test Gastroenterology and Hepatology Hospitals Humans Mass Screening - ethics Medical screening Mortality Occult Blood Occult sciences screening |
title | Ethical issues in colorectal cancer screening |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A41%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethical%20issues%20in%20colorectal%20cancer%20screening&rft.jtitle=Bailli%C3%A8re's%20best%20practice%20&%20research.%20Clinical%20gastroenterology&rft.au=van%20Dam,%20Leonie,%20MD,%20PhD&rft.date=2014-04-01&rft.volume=28&rft.issue=2&rft.spage=315&rft.epage=326&rft.pages=315-326&rft.issn=1521-6918&rft.eissn=1532-1916&rft.coden=BPRCB6&rft_id=info:doi/10.1016/j.bpg.2014.03.002&rft_dat=%3Cproquest_cross%3E3294637491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521030212&rft_id=info:pmid/24810192&rft_els_id=S1521691814000262&rfr_iscdi=true |